Rallybio Announces Initiation of Phase 2 Clinical Trial of RLYB212

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/26/2026

1. NVDA
2. SPY
3. AAPL
4. DKS
5. USO
6. XPEV
7. BMO
8. VEEV
9. GRML
10. MU

Go back to Rallybio Announces Initiation of Phase 2 Clinical Trial of RLYB212
(NASDAQ: RLYB) Delayed: 16.89 +0.09 (0.54%)
Previous Close $16.80    52 Week High $ 
Open $16.81    52 Week Low $ 
Day High $17.03    P/E N/A 
Day Low $16.64    EPS $ 
Volume 7,447